We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 10

Chinese drywall first bellwether trial ongoing

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • March 9 2010

The first federal trial in the nationwide Chinese drywall controversy began on February 19th, 2010 in New Orleans and is ongoing

Jury finds in favor of botox manufacturer in off-label use trial

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • May 28 2010

A California jury recently returned a verdict in favor of Allergan, Inc., in a trial involving claims that Allergan’s promotion of an off-label use of its drug Botox caused the death of a pediatric patient suffering from cerebral palsy

Florida federal court judge sends insurer’s Chinese Drywall suit to New Orleans MDL

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • October 14 2010

On September 22, 2010, a U.S. District Court Judge in the Middle District of Florida transferred an insurer’s Chinese Drywall coverage case to the District Court in New Orleans, where Multi-District Chinese Drywall Litigation is pending

Eight Circuit rejects FDA preemption defense raised by generic drug manufacturers

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • February 10 2010

On November 27, 2009, the United States Court of Appeals for the Eighth Circuit held that failure to warn claims directed at generic pharmaceutical manufacturers are not preempted by federal law

Chinese drywall - manufacturers still refusing to compensate U.S. homeowners

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • January 12 2011

Inez Tenenbaum, the head of the U.S. Consumer Product Safety Commission, said this week that the U.S. has not been able to persuade Chinese officials to agree to compensate U.S. homeowners for losses associated with Chinese manufactured drywall

Chinese drywall IRS approves tax break for Chinese drywall remediation

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • October 26 2010

The Internal Revenue Service recently approved a rule that would permit taxpayers with defective drywall in their houses to deduct the cost of repairs and replacement of damaged appliances

Chinese drywall manufacturer agrees to fund remediation pilot program

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • October 27 2010

Chinese drywall manufacturer Knauf Plasterboard Tianjin Company ("Knauf"), has agreed to pay to repair 300 homes in four states in a remediation pilot program

Jury awards $141 million against Pfizer in connection with off-label use of Neurontin

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • April 7 2010

A federal jury in Boston recently returned a verdict against Pfizer Inc. in connection with claims that Pfizer unlawfully promoted off-label uses of its anti-epilepsy drug Neurontin

Chinese drywall HUD and CPSC issue guidance on remediation of Chinese drywall

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • May 10 2010

On Friday April 2, 2010, the U.S. Department of Housing and Urban Development (HUD) and the U.S. Consumer Product Safety Commission (CPSC) issued “interim remediation guidance” to homeowners impacted by Chinese manufactured drywall

Learned intermediary doctrine: Eleventh Circuit upholds summary judgment in favor of manufacturer in lawsuit claiming antidepressant caused suicide

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • May 28 2010

The 11th Circuit Court of Appeals recently relied upon the learned intermediary doctrine in affirming summary judgment in favor of Smithkline Beecham Corp. (“SBC”) in a lawsuit claiming that the antidepressant Paxil caused the decedent to commit suicide